Clarix Imaging Secures $10 Million in New Funding from kineo finance to Transform Surgical Oncology
Summary
Due to its potential to benefit the 300,000 patients diagnosed with breast cancer in the US annually, Clarix Imaging has seen a surge in demand since commercialization and will use this infusion and an upcoming equity financing round to foster growth and development. Clarix Imaging has demonstrated remarkable traction by addressing a fundamental unmet need in lumpectomies, and we are extremely excited to welcome them to our portfolio of companies, said Lee Hsieh, Senior Vice President of kineo finance. This technological breakthrough enabled Clarix Imaging to create a portable system that seamlessly meets the space and time demands necessary for use within the operating room workflow so surgeons and radiologists receive rapid verification that the correct tissue has been excised. Unrivaled with its precision and workflow-oriented software, VSI-360 generates a true 3D representation of the specimen and allows users to visualize the tumor in thin image slices without overlapping tissues obscuring the margins. Established by prominent Europe-based institutions, kineo offers a broad industry network and know-how and actively supports high-growth companies to accelerate the market entry of their innovations.
Funding
Review available funding amount, funding date, investors, and linked company information related to Clarix Imaging Secures $10 Million in New Funding from kineo finance to Transform Surgical Oncology in the interactive ISVWorld profile.